Goa Pharmaceuticals Manufacturers Association
Goa Pharmaceuticals Manufacturers Association


Goa Pharmaceutical Manufacturers' Association is a registered body formed with the objective of uniting the pharmaceutical manufacturers’ in Goa, so as to come on a common platform to interact and exchange views and ideas, to work on common problems with local and Government authorities in Goa and share our experiences in labour handling front and any Government issues.

GPMA is an autonomous body not affiliated to any institutions like IDMA or OPPI and as stated above, its purpose is to deal at any local level. This Association gives an excellent opportunity to all of us to know each other, which facilitates in our professional endeavour.

GPMA in Goa is unique and it comprises of members of Small, Medium and Large-Scale industrial units. Our member companies belong to the Indian Private Sector, Public Sector and Multinational companies including manufacturers of Pharmaceutical drug products, excipients, medical diagnostics, ayurdevic medicines, cosmetics, etc.

GPMA aims to foster harmony and create and sustain an environment conducive to growth of Pharma industry in Goa. The aim of association is to act as a catalyst between its members and the government by working together on Policy related issues and also provide a platform to share common problems faced by the Pharma industry.

GPMA is recognized by the Government of Goa. We are also, wherever necessary called upon to represent in advisory bodies in the government for e.g. Food and Drugs Administration, Central and State Excise Department, Labour Department, GSPCB, Goa College of Pharmacy, State Craftsman Vocational Training (ITI), etc.


  1. GPMA is registered as a Trust and carry out several philanthropic activities. Donation of medicines to several NGOs, like Baba Amte’s Maharogi Seva Samiti. Rotary club, Lions Club, local Village Panchayats etc and holding medical and diagnostics camps. Scholarship to needy and meritorious students, lately donated medicines to Canacona Flood Relief Programme.
  2. GPMA is affiliated to the Confederation of Indian Pharmaceutical Industry (CIPI), which is a very active body at the National level. Earlier it had made strong representations on the issues on fixed Dose Combination with DCGI, wherever correct rationale could be advanced. Presently, it has obtained stay from the High Court on the DCGI order, of the State Licensing Authority’s Grant of issue of COPP on behalf of all its member manufacturers.
  3. GPMA made representation to the "Parliamentary Standing Committee" headed by Mr. Amar Singh and Digvijay Singh on our concerns in formation of Central Drug Authority. We had submitted a detail written submission highlighting several areas to our objection on the formation of the Central Drug Authority, as State Drug Licensing Authority is fully empowered to deal in licensing of drugs as this is a State related subject. Industries in Goa will be at a serious disadvantage in seeking license and day to day regulatory mattes from DCGI / CDSCO office in New Delhi. Matter has also been taken up with the Hon’ble M.P. Mr. Shantaram Naik for representation in the Parliament.
  4. Conducted meetings with Director of FDA, Mr. Promod Kumar Jain to speed up clearance of files, issue of COPP, Export licenses etc., creation of separate cell for export so as to clear all the pending matters within a week. 
  5. Conducted meetings with Honorable Health Minister regarding :
    1. Payment of fees in FDA
    2. Abolition of Entry Tax
    3. WHO Certification extension to additional products
    4. Licensing of existing fixed dose combinations and other matters. Arising out of DCGI
  6. Provided necessary help and support to Marion Institute of Health Sector Management to set up in Goa by Fr. Romauld D’Souza, Founder and Director of GIM and XLRI, Jamshedpur.
  7. Organized an advanced level Seminar on "Enhancing Quality and Regulatory Compliance in the Pharmaceutical Industry" for senior management staff of the Pharmaceutical Industry.
  8. Organized a Training Programme on "Environment Management" in co-ordination with the Goa State Pollution Control Board.
  9. Participated with CII on Pharma education and skill deficiency mapping along with Goa College of Pharmacy and pharmaceutical industry in Goa.
  10. Organized a Technical seminar on "Quality Risk Management - ICH Q9" by Mr. Pravin Mankar, Director of Bombay College of Pharmacy as a part of GPMA's continuous training programme.
  11. Meeting was held with the Director of Industries to carry forward Pharmaceutical Cluster Development Programme especially in the area of Hazardous Waste Management and Disposal. Formation of a common site for incineration of pharmaceutical hazardous waste as 99% of the pharmaceutical hazardous waste needs to be incinerated.
  12. Organized a seminar on "Energy Efficiency improvement and Cost Saving opportunities in the Pharmaceutical Industry". This was highly appreciated by the industry participants.
  13. Made a representation to Dr. Vijay Kelkar, Dy. Chairman of Planning Commission on
    1. DPCO, price control and other impediments faced by Pharma industry. In spite of steady increase in price of several inputs, there is inordinate delay in commensurate increase in price of formulations by NPPA. 
    2. Demand made for free license of Pharmacopoeial products by State Licensing Authority. 
    3. Abolition of Entry Tax and to incentives for small state like Goa, which has locational disadvantage with respect to material sourcing and finished product market.
    4. Formation of a branch of NIPER to facilitate education and research at Goa as it is pharmaceutical hub.
  14. Made a representation to the Labour Ministry and proposed formation of a working group to study the revision of "Minimum Wages" of several grades of workmen under various categories in the industry in Goa. The proposal was accepted and a representative committee was formed under the chairman ship of the Labour Commissioner.
  15. Assisted Dhempe College of Science for its P.G. Diploma Program on pharmaceutical analytical techniques by assisting in training and also providing scholarship to two students.
  16. Worked in close coordination with the Office of the Development Commissioner of MSME to facilitate members on various schemes.
  17. Organized an interactive session with Dr. G. N. Singh, Director, IPCL Ghaziabad, and Mr. Debashish Panda, Joint Secretary, Ministry of Health and Family Welfare following the launch of the 2007 edition of Indian Pharmacopoeia.
  18. Made a representation to the Drug Controller General of India, to revise COPP registration to five years and grant of WHO GMP Certification also for the same period of five years. 
  19. Participated with Government of Goa to upgrade ITI’s under the constitution of State committees for skill development.
  20. Conducted a meeting with Dr. Ashok Vishandass, Dy. Director General, Department of Pharmaceuticals, on Awareness building Workshop at Goa. Providing capital subsidy scheme for financial assistance to Pharma SSI units for up gradation and compliance of Schedule M.
  21. Made a representation to the Goa State Pollution Control Board, on classification of Pharma industry in the green category as it is non polluting and non hazardous. Mr. Cesar Menezes, as a member of GCCI, also represented GPMA. 
  22. GPMA alongwith GCCI discusses the possibility of having Customs procedures for clearance under RA/Adv. License in Goa on the same lines as existing in Mumbai Customs. However, this may be feasible, after Goa being notified as port for import and export.

GPMA has very actively taken up and resolved many major issues of Pharmaceutical Industry and contributed in enhancing the knowledge base of the members.


  1. Creation of the common Hazardous waste incineration plant under the Cluster Development Program with the active support and help from Director of Industries and Mines and Goa State Pollution Control Board.
  2. Notifying Goa port, both air and sea as a point of Entry and Exit for import and export of pharmaceuticals. For this, the industry engaged in import and export, should forward the business data, based o which this can be feasible.
  3. DCGI should open an office of CDSCO in Goa, as Goa is a major pharmaceutical hub, to facilitate export.
  4. Better intra industry coordination on IR and other industry issues.
Sr. No. Activity Date
1. Awareness proramme on cluster approach for the Development of Goa Pharmaceuticals Cluster of the Ministry of SSI, Government of India 29.10.2003
2. Workshop of GMP / Schedule – M in Association with SISI, Minister of SSI, Government of India and SIDBI 25.03.2004
3. Workshop of pharmaceutical packaging in association with SSI and Indian Institute of Packaging, Mumbai 21.08.04 and 22.08.04
4. Interface with bankers in association with SISI and SBI 07.10.04
5. Interface with business development service providers for technology upgradation to meet Schedule M requirements, in association with SISI, SIDBI and private pharma consultants 27.10.04
6. Arranged pre-assessment of 14 pharma companies for implementation of Schedule M During November 2005 to June 2005
7. Facilitation of implementation of ISO quality certification for 3 companies - do -
8. Programme on Energy conservation in association with SISI and PCRA, Mumbai 25.12.04
9. Energy Audits of 6 pharma companies Jan-March 06
10. Workshop on intellectual property rights ( IPR) in association with SISI and NIPER, Mohali, Chandigarh 25.03.04
11. Workshop for pharma plant engineers in association with SISI CDSCO, Mumbai 20.03.06 – 21.03.06
12. Seminar on development of SMEs in pharma sector in association with SISI and Canara Bank 14.10.05
13. Art and Science of pharma exports in association wit SISI and global networks, Ahemdabad 27.01.06 and 28.01.06
14. Total production management in association with SISI, CDSCO, Mumbai and NIPER, Mohali 10.01.06 and 10.01.06
15. Interface with SES, Germany India Representative Nov’05
16. Total Quality Management in association with SISI and NIPER, Mohali. 8.09.06 and 09.09.06
  Forthcoming activities :  
a) Seminar on international audits Dec’06
b) Delegation to CIS countries Feb’07
c) Calibration and validation of analytical equipments Jan to March 06
d) Energy audits - do -
e) Programme for plant engineers Jan 2007.
Important Links

News Updates


The Goa Pharmaceuticals Manufacturers’ Association had the formal roll out of its Vision and Miss..... | read more

Global Pharma Market And Indian Pharmaceutical Industry an overview By Dr. Praveen Khullar, GPMA

Dr. Khullar in his Presidential address gave an overview of the Global Pharmaceutical scenario..... | read more

GPMA – Change of Guard

The Goa Pharmaceuticals Manufacturers’ Association (GPMA) held its Annual General Body Meeting on..... | read more